Laboratory tests, including hematological assessments, contribute additional diagnostic insights by identifying specific biomarkers associated with PAH, such as brain natriuretic peptide (BNP) or N-terminal pro-brain natriuretic peptide (NT-proBNP). The gene discussed is NPPB; the disease is pulmonary arterial hypertension.